Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial - Galimberti, V; Cole, B F; Viale, G (Lancet Oncol, 2018)